Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.
BACKGROUND: Obstructive sleep apnoea (OSA) is associated with high cardiovascular morbidity and mortality and is an independent risk factor for hypertension. Novel circulating cardiovascular risk markers enabling a more accurate prediction of cardiovascular risk have been identified. Examination of...
Main Authors: | Robinson, G, Pepperell, J, Segal, H, Davies, R, Stradling, JR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Caffeine levels following treatment of obstructive sleep apnoea.
by: Robinson, G, et al.
Published: (2003) -
Systemic hypertension and obstructive sleep apnoea.
by: Pepperell, J, et al.
Published: (2002) -
Platelet activation is increased in obstructive sleep apnoea and does not fall with CPAP treatment
by: Robinson, G, et al.
Published: (2002) -
Sleep studies for sleep apnoea.
by: Pepperell, J, et al.
Published: (2002) -
Continuous positive airway pressure and liver enzymes in obstructive sleep apnoea: data from a randomized controlled trial.
by: Kohler, M, et al.
Published: (2009)